0001133228-14-003858.txt : 20141022 0001133228-14-003858.hdr.sgml : 20141022 20141022140624 ACCESSION NUMBER: 0001133228-14-003858 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20141022 DATE AS OF CHANGE: 20141022 EFFECTIVENESS DATE: 20141022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHN HANCOCK CALIFORNIA TAX-FREE INCOME FUND CENTRAL INDEX KEY: 0000856671 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-31675 FILM NUMBER: 141167455 BUSINESS ADDRESS: STREET 1: 601 CONGRESS STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-663-3000 MAIL ADDRESS: STREET 1: C/O JOHN HANCOCK FUNDS STREET 2: 601 CONGRESS STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: JOHN HANCOCK CALIFORNIA TAX FREE INCOME FUND DATE OF NAME CHANGE: 20110214 FORMER COMPANY: FORMER CONFORMED NAME: HANCOCK JOHN CALIFORNIA TAX FREE INCOME FUND DATE OF NAME CHANGE: 19941227 FORMER COMPANY: FORMER CONFORMED NAME: TRANSAMERICA CALIFORNIA TAX FREE INCOME FUND DATE OF NAME CHANGE: 19920703 0000856671 S000000616 HANCOCK JOHN CALIFORNIA TAX FREE INCOME FUND C000001742 Class A TACAX C000001743 Class B TSCAX C000001744 Class C TCCAX 497 1 e391750_497.htm SUPPLEMENT TO THE SAI

Supplement dated October 22, 2014

to the current Statement of Additional Information, as may be supplemented

 

The following information supplements and supersedes any information to the contrary contained in the Statement of Additional Information.

 

Effective December 22, 2014, the last paragraph in the “Description of the Funds’ Shares” section is hereby revised and restated as follows:

 

Shares of a Fund generally may be sold only to U.S. citizens, U.S. residents and U.S. domestic corporations, partnerships, trusts, or estates. For purposes of this policy, U.S. citizens and U.S. residents must reside in the U.S. and U.S. domestic corporations, partnerships, trusts, and estates must have a U.S. address of record.

 

You should read this Supplement in conjunction with the Statement of Additional Information and retain it for your future reference.